Home » Tenders » Americas » Brazil » Record of Prices for the Acquisition of Medicines, Belonging to Class(Es) 6505. Tender

Record of Prices for the Acquisition of Medicines, Belonging to Class(Es) 6505. Tender

Download Documents

RIO DE JANEIRO CITY HALL has floated a tender for Record of Prices for the Acquisition of Medicines, Belonging to Class(Es) 6505.. The project location is Brazil and the tender is closing on 04 Apr 2024. The tender notice number is 90201/2024, while the TOT Ref Number is 99072652. Bidders can have further information about the Tender and can request the complete Tender document by Registering on the site.

Procurement Summary

Country : Brazil

Summary : Record of Prices for the Acquisition of Medicines, Belonging to Class(Es) 6505.

Deadline : 04 Apr 2024

Other Information

Notice Type : Tender

TOT Ref.No.: 99072652

Document Ref. No. : 90201/2024

Competition : ICB

Financier : Self Financed

Purchaser Ownership : Public

Tender Value : Refer Document

Purchaser's Detail

Purchaser : RIO DE JANEIRO CITY HALL
Rua Afonso Cavalcanti, nr.455 Cidade Nova Tel.021 22735413 Fax021 - Cidade Nova - Rio de Janeiro (RJ)
Telephone: (0xx21) 29762022
Fax: (0xx21)
Brazil

Tender Details

Object: Electronic Auction - Record of prices for the acquisition of medicines, belonging to class(es) 6505.

UASG Code: 986001

Notice from: 03/19/2024 from 08:00 to 17 :59 Hrs

Proposal Delivery: from 03/19/2024 at 08:00Hs

GLUCAGON, DOSAGE 1 MG, PHARMACEUTICAL FORM LIOFI POWDER19981d172c851bd4e8a1788d5726c2d3LO FOR INJECTABLE

Quantity: 12

INSULIN, ASPARTE ORIGIN ASSOCIATED WITH ASPARTE PROTAMINE, CONCENTRATION 30% 70%, 100 IU/ML, PHARMACEUTICAL FORM INJECTABLE SOLUTION

Quantity: 48

INSULIN, DEGLUDECA TYPE ASSOCIATED WITH LIRAGLUTIDE, CONCENTRATION 100 U/ ML 3.6 MG/ML, PHARMACEUTICAL FORM INJECTABLE SOLUTION, AD19981d172c851bd4e8a1788d5726c2d3Ideal with application system

Quantity: 20

insulin, degludeca type, concentration 200 UI/mL, pharmaceutical form injectable solution, additional characteristic with applicator

quantity: 1620

insulin, degludeca type, concentration 200 UI/ml, pharmaceutical form solution INJECTABLE, ADI FEATURE19981d172c851bd4e8a1788d5726c2d3TIONAL WITH APPLICATOR

Quantity: 180

INSULIN, DEGLUDECA TYPE, CONCENTRATION 100 IU/ML, PHARMACEUTICAL FORM INJECTABLE SOLUTION, ADDITIONAL CHARACTERISTICS REFIL

Quantity: 1620

INSULIN, DEGLUDECA TYPE, CONCENTRATION 100 IU/ML, PHARMACEUTICAL FORM INJECTABLE SOLUTION EL, ADDITIONAL FEATURE REFIL

Quantity19981d172c851bd4e8a1788d5726c2d3Quantity: 180

INSULIN, GLARGINE TYPE, CONCENTRATION 300 IU/ML, PHARMACEUTICAL FORM INJECTABLE SOLUTION, ADDITIONAL CHARACTERISTICS WITH APPLICATOR

Quantity: 360

INSULIN, LISPRO TYPE ASSOCIATED WITH LISPRO PROTAMINE, CONCENTRATION 25% 75%, 100 IU/ML, FORM PHARMACEUTICA INJECTABLE SOLUTION, ADICI FEATURE19981d172c851bd4e8a1788d5726c2d3ONAL WITH APPLICATOR

Quantity: 60